The elevated serum or plasma levels of MMP9 were observed in patients with colorectal,[10] gastric,[16] lung,[17] and breast cancer[18] but decreased levels were seen in patients with bone tumors[19] and multiple myeloma [20] and some breast cancers.[21]. Here, MMP9 is linked to plasma cell myeloma.